Literature DB >> 31925619

Production of radiometals in liquid targets.

Sergio J C do Carmo1, Peter J H Scott2, Francisco Alves3,4.   

Abstract

Over the last several years, the use of radiometals has gained increasing relevance in supporting the continuous development of new, complementary and more specific biological targeting agents. Radiopharmaceuticals labelled with radiometals from elements such as Tc, Zr, Y, Ga and Cu received increasing attention as they find application in both diagnostic SPECT and PET imaging techniques and radiotherapeutic purposes. Such interest stems from the wide variety of radionuclides available with distinct and complementary nuclear decay characteristics to choose from with unequalled specificity, but can also be explained by growing demand in targeted radionuclide therapy. As a result, as routine supply of these radiometals becomes mandatory, studies describing their production processes have expanded rapidly. Although most radiometals are traditionally provided by the irradiation of solid targets in specialized cyclotrons, recently developed techniques for producing radiometals through the irradiation of liquid targets have received growing attention due to compatibility with commonly available small medical cyclotrons, promising characteristics and encouraging results. Irradiating liquid targets to produce radiometals appears as a fast, reliable, convenient and cost-efficient alternative to the conventional solid target techniques, characterized by complex and time-consuming pre- and post-irradiation target handling. Production of radiometals in liquid targets incorporated to complete manufacturing processes for daily routine is already recognized as a viable alternative and complementary supply methodology to existing solid target based infrastructures to satisfy growing clinical demands. For instance, several sites already use the approach to produce 68Ga-radiopharmaceuticals for clinical use. This review article covers the production of common radiometals with clinical potential through the irradiation liquid targets. A comparison with the traditional solid target irradiation methods is presented when relevant.

Entities:  

Keywords:  Cyclotron; Liquid target; Radioisotope production; Radiometals

Year:  2020        PMID: 31925619      PMCID: PMC6954154          DOI: 10.1186/s41181-019-0088-x

Source DB:  PubMed          Journal:  EJNMMI Radiopharm Chem        ISSN: 2365-421X


  36 in total

1.  Post-elution processing of (44)Ti/(44)Sc generator-derived (44)Sc for clinical application.

Authors:  M Pruszyński; N S Loktionova; D V Filosofov; F Rösch
Journal:  Appl Radiat Isot       Date:  2010-04-24       Impact factor: 1.513

2.  Simultaneous production of high specific activity 64Cu and 61Co with 11.4 MeV protons on enriched 64Ni nuclei.

Authors:  Miguel A Avila-Rodriguez; Jonathon A Nye; Robert J Nickles
Journal:  Appl Radiat Isot       Date:  2007-07-03       Impact factor: 1.513

3.  High efficiency production and purification of 86Y based on electrochemical separation.

Authors:  Dragoljub Lukić; Claire Tamburella; Franz Buchegger; Gerd-Jürgen Beyer; Jozef J Comor; Yann Seimbille
Journal:  Appl Radiat Isot       Date:  2008-12-24       Impact factor: 1.513

4.  Preparation of high specific activity (86)Y using a small biomedical cyclotron.

Authors:  Jeongsoo Yoo; Lucie Tang; Todd A Perkins; Douglas J Rowland; Richard Laforest; Jason S Lewis; Michael J Welch
Journal:  Nucl Med Biol       Date:  2005-11       Impact factor: 2.408

5.  Production of 89Zr via the 89Y(p,n)89Zr reaction in aqueous solution: effect of solution composition on in-target chemistry.

Authors:  Mukesh K Pandey; Hendrik P Engelbrecht; John P Byrne; Alan B Packard; Timothy R DeGrado
Journal:  Nucl Med Biol       Date:  2014-01-17       Impact factor: 2.408

Review 6.  Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals.

Authors:  Johannes Notni; Hans-Jürgen Wester
Journal:  J Labelled Comp Radiopharm       Date:  2017-12-29       Impact factor: 1.921

7.  Molecular imaging with copper-64.

Authors:  Suzanne V Smith
Journal:  J Inorg Biochem       Date:  2004-11       Impact factor: 4.155

Review 8.  Copper radionuclides and radiopharmaceuticals in nuclear medicine.

Authors:  P J Blower; J S Lewis; J Zweit
Journal:  Nucl Med Biol       Date:  1996-11       Impact factor: 2.408

9.  Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotron.

Authors:  Atsushi Obata; Shingo Kasamatsu; Deborah W McCarthy; Michael J Welch; Hideo Saji; Yoshiharu Yonekura; Yasuhisa Fujibayashi
Journal:  Nucl Med Biol       Date:  2003-07       Impact factor: 2.408

10.  Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators.

Authors:  Rubel Chakravarty; Sudipta Chakraborty; Ashutosh Dash; M R A Pillai
Journal:  Nucl Med Biol       Date:  2012-12-04       Impact factor: 2.408

View more
  6 in total

1.  Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets.

Authors:  Alexandra I Fonseca; Vítor H Alves; Sérgio J C do Carmo; Magda Silva; Ivanna Hrynchak; Francisco Alves; Amílcar Falcão; Antero J Abrunhosa
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-07

2.  Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers.

Authors:  Jianfeng Xu; Fei Cai; Zhigang Luo; Wenbin Fan; Juan Dai; Jingjing Cui; Shihong Li; Changran Geng; Qihuang Zheng; Zheng Wang; Xiaobin Tang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-26       Impact factor: 10.057

3.  Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target.

Authors:  Melissa E Rodnick; Carina Sollert; Daniela Stark; Mara Clark; Andrew Katsifis; Brian G Hockley; D Christian Parr; Jens Frigell; Bradford D Henderson; Monica Abghari-Gerst; Morand R Piert; Michael J Fulham; Stefan Eberl; Katherine Gagnon; Peter J H Scott
Journal:  EJNMMI Radiopharm Chem       Date:  2020-11-12

Review 4.  Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy.

Authors:  Romain Eychenne; Christelle Bouvry; Mickael Bourgeois; Pascal Loyer; Eric Benoist; Nicolas Lepareur
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

Review 5.  Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals?

Authors:  Nicolas Lepareur
Journal:  Front Med (Lausanne)       Date:  2022-02-10

Review 6.  Production Review of Accelerator-Based Medical Isotopes.

Authors:  Yiwei Wang; Daiyuan Chen; Ricardo Dos Santos Augusto; Jixin Liang; Zhi Qin; Juntao Liu; Zhiyi Liu
Journal:  Molecules       Date:  2022-08-19       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.